Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Multiple Sclerosis

  Free Subscription


01.01.2018

1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
1 Arch Phys Med Rehabil
1 Can J Neurol Sci
2 J Neurol
2 J Neurol Neurosurg Psychiatry
2 J Neurol Sci
6 Lancet Neurol
2 Mult Scler
1 Neurology
1 Proc Natl Acad Sci U S A
1 Rev Neurol
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. OLSSON A, Oturai AB, Sondergaard HB, Sellebjerg F, et al
    Bone microarchitecture and bone mineral density in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 21. doi: 10.1111/ane.12884.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. AYMERICH FX, Auger C, Alonso J, Alberich M, et al
    Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Dec 28. pii: ajnr.A5495. doi: 10.3174/ajnr.A5495.
    PubMed     Text format     Abstract available


    Arch Phys Med Rehabil

  3. PEEBLES AT, Bruetsch AP, Lynch SG, Huisinga JM, et al
    Dynamic balance is related to physiological impairments in persons with multiple sclerosis.
    Arch Phys Med Rehabil. 2017 Dec 21. pii: S0003-9993(17)31405.
    PubMed     Text format     Abstract available


    Can J Neurol Sci

  4. TURCOTTE LA, Marrie RA, Patten SB, Hirdes JP, et al
    Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care.
    Can J Neurol Sci. 2017 Dec 18:1-11. doi: 10.1017/cjn.2017.
    PubMed     Text format     Abstract available


    J Neurol

  5. BRENTON JN, Schreiner T, Karoscik K, Richter M, et al
    Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis.
    J Neurol. 2017 Dec 22. pii: 10.1007/s00415-017-8715.
    PubMed     Text format     Abstract available

  6. FRAU J, Villar LM, Sardu C, Secci MA, et al
    Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
    J Neurol. 2017 Dec 22. pii: 10.1007/s00415-017-8716.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  7. PATTI F
    Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Dec 23. pii: jnnp-2017-317380.
    PubMed     Text format    

  8. STURNER KH, Stellmann JP, Dorr J, Paul F, et al
    A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317101.
    PubMed     Text format     Abstract available


    J Neurol Sci

  9. DALLA-COSTA G, Radaelli M, Maida S, Sangalli F, et al
    Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice.
    J Neurol Sci. 2017;383:166-168.
    PubMed     Text format     Abstract available

  10. LINGENBERG A, Laidet M, Armand S, Herrmann FR, et al
    Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis.
    J Neurol Sci. 2017;383:105-107.
    PubMed     Text format    


    Lancet Neurol

  11. BOVE RM, Hauser SL
    Diagnosing multiple sclerosis: art and science.
    Lancet Neurol. 2017 Dec 21. pii: S1474-4422(17)30461.
    PubMed     Text format    

  12. CALABRESI PA
    Advances in multiple sclerosis: from reduced relapses to remedies.
    Lancet Neurol. 2018;17:10-12.
    PubMed     Text format    

  13. FILIPPI M, Preziosa P, Meani A, Ciccarelli O, et al
    Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Lancet Neurol. 2017 Dec 21. pii: S1474-4422(17)30469.
    PubMed     Text format     Abstract available

  14. CROSS AH, Naismith RT
    Refining the use of MRI to predict multiple sclerosis.
    Lancet Neurol. 2017 Dec 21. pii: S1474-4422(17)30459.
    PubMed     Text format    

  15. THOMPSON AJ, Banwell BL, Barkhof F, Carroll WM, et al
    Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
    Lancet Neurol. 2017 Dec 21. pii: S1474-4422(17)30470.
    PubMed     Text format     Abstract available

  16. BURTON A
    Multiple sclerosis: what's it got to do with your guts?
    Lancet Neurol. 2017 Dec 20. pii: S1474-4422(17)30468.
    PubMed     Text format    


    Mult Scler

  17. CALLESEN J, Richter C, Kristensen C, Sunesen I, et al
    Test-retest agreement and reliability of the Six Spot Step Test in persons with multiple sclerosis.
    Mult Scler. 2017 Dec 1:1352458517745725. doi: 10.1177/1352458517745725.
    PubMed     Text format     Abstract available

  18. PEETERS LM
    Fair data for next-generation management of multiple sclerosis.
    Mult Scler. 2017 Dec 1:1352458517748475. doi: 10.1177/1352458517748475.
    PubMed     Text format     Abstract available


    Neurology

  19. PISA M, Guerrieri S, Di Maggio G, Medaglini S, et al
    No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS.
    Neurology. 2017;89:2469-2475.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  20. ITOH N, Itoh Y, Tassoni A, Ren E, et al
    Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes.
    Proc Natl Acad Sci U S A. 2017 Dec 26. pii: 1716032115.
    PubMed     Text format     Abstract available


    Rev Neurol

  21. MIDAGLIA L, Mora L, Mulero P, Sastre-Garriga J, et al
    [Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis].
    Rev Neurol. 2018;66:25-32.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  22. BACH JF
    Causality and complex disease: The example of multiple sclerosis.
    Rev Neurol (Paris). 2017 Dec 19. pii: S0035-3787(17)30846.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: